Cargando…

Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan

PURPOSE: There are still evidence gaps on the prevalence of airflow limitation in Japan. The purpose of this survey was to estimate the prevalence of airflow limitation among healthy subjects in Japan and to show what proportion of subjects with airflow limitation had been diagnosed with chronic obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Omori, Hisamitsu, Kaise, Toshihiko, Suzuki, Takeo, Hagan, Gerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853170/
https://www.ncbi.nlm.nih.gov/pubmed/27217740
http://dx.doi.org/10.2147/COPD.S99935
_version_ 1782430046741331968
author Omori, Hisamitsu
Kaise, Toshihiko
Suzuki, Takeo
Hagan, Gerry
author_facet Omori, Hisamitsu
Kaise, Toshihiko
Suzuki, Takeo
Hagan, Gerry
author_sort Omori, Hisamitsu
collection PubMed
description PURPOSE: There are still evidence gaps on the prevalence of airflow limitation in Japan. The purpose of this survey was to estimate the prevalence of airflow limitation among healthy subjects in Japan and to show what proportion of subjects with airflow limitation had been diagnosed with chronic obstructive pulmonary disease (COPD). SUBJECTS AND METHODS: This was an observational, cross-sectional survey targeting multiple regions of Japan. Subjects aged 40 years or above who were undergoing comprehensive health examination were recruited from 14 centers in Japan. Airflow limitation was defined as having forced expiratory volume in 1 second/forced vital capacity less than 70%. RESULTS: In a total of 22,293 subjects, airflow limitation was most prevalent in subjects aged over 60 years (8.7%), but was also observed in subjects aged 50–59 years (3.1%) and 40–49 years (1.7%). Overall prevalence was 4.3%. Among subjects with smoking history (n=10,981), the prevalence of airflow limitation in each age group (12.8% in those aged over 60 years, 4.4% in those aged 50–59 years, and 2.2% in those aged 40–49 years) and overall prevalence (6.1%) were higher than that of total subjects. Of the smokers with airflow limitation, 9.4% had been diagnosed with COPD/emphysema and 27.3% with other respiratory diseases. CONCLUSION: Among smokers undergoing comprehensive health examination, prevalence of airflow limitation reached 12.8% in those aged over 60 years and airflow limitation was observed in subjects aged 40–59 years as well, though their prevalence was lower than that in subjects aged over 60 years. We demonstrated that a significant proportion of smokers with airflow limitation had not been diagnosed with COPD/emphysema, suggesting that some of them can be diagnosed with COPD or other respiratory diseases by a detailed examination after comprehensive health examination. Screening for subjects at risk of COPD by spirometry in comprehensive health examination starting at 40 years of age, followed by a detailed examination, may be an effective approach to increase the diagnosis of COPD.
format Online
Article
Text
id pubmed-4853170
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48531702016-05-23 Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan Omori, Hisamitsu Kaise, Toshihiko Suzuki, Takeo Hagan, Gerry Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: There are still evidence gaps on the prevalence of airflow limitation in Japan. The purpose of this survey was to estimate the prevalence of airflow limitation among healthy subjects in Japan and to show what proportion of subjects with airflow limitation had been diagnosed with chronic obstructive pulmonary disease (COPD). SUBJECTS AND METHODS: This was an observational, cross-sectional survey targeting multiple regions of Japan. Subjects aged 40 years or above who were undergoing comprehensive health examination were recruited from 14 centers in Japan. Airflow limitation was defined as having forced expiratory volume in 1 second/forced vital capacity less than 70%. RESULTS: In a total of 22,293 subjects, airflow limitation was most prevalent in subjects aged over 60 years (8.7%), but was also observed in subjects aged 50–59 years (3.1%) and 40–49 years (1.7%). Overall prevalence was 4.3%. Among subjects with smoking history (n=10,981), the prevalence of airflow limitation in each age group (12.8% in those aged over 60 years, 4.4% in those aged 50–59 years, and 2.2% in those aged 40–49 years) and overall prevalence (6.1%) were higher than that of total subjects. Of the smokers with airflow limitation, 9.4% had been diagnosed with COPD/emphysema and 27.3% with other respiratory diseases. CONCLUSION: Among smokers undergoing comprehensive health examination, prevalence of airflow limitation reached 12.8% in those aged over 60 years and airflow limitation was observed in subjects aged 40–59 years as well, though their prevalence was lower than that in subjects aged over 60 years. We demonstrated that a significant proportion of smokers with airflow limitation had not been diagnosed with COPD/emphysema, suggesting that some of them can be diagnosed with COPD or other respiratory diseases by a detailed examination after comprehensive health examination. Screening for subjects at risk of COPD by spirometry in comprehensive health examination starting at 40 years of age, followed by a detailed examination, may be an effective approach to increase the diagnosis of COPD. Dove Medical Press 2016-04-22 /pmc/articles/PMC4853170/ /pubmed/27217740 http://dx.doi.org/10.2147/COPD.S99935 Text en © 2016 Omori et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Omori, Hisamitsu
Kaise, Toshihiko
Suzuki, Takeo
Hagan, Gerry
Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan
title Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan
title_full Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan
title_fullStr Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan
title_full_unstemmed Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan
title_short Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan
title_sort prevalence of airflow limitation in subjects undergoing comprehensive health examination in japan: survey of chronic obstructive pulmonary disease patients epidemiology in japan
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853170/
https://www.ncbi.nlm.nih.gov/pubmed/27217740
http://dx.doi.org/10.2147/COPD.S99935
work_keys_str_mv AT omorihisamitsu prevalenceofairflowlimitationinsubjectsundergoingcomprehensivehealthexaminationinjapansurveyofchronicobstructivepulmonarydiseasepatientsepidemiologyinjapan
AT kaisetoshihiko prevalenceofairflowlimitationinsubjectsundergoingcomprehensivehealthexaminationinjapansurveyofchronicobstructivepulmonarydiseasepatientsepidemiologyinjapan
AT suzukitakeo prevalenceofairflowlimitationinsubjectsundergoingcomprehensivehealthexaminationinjapansurveyofchronicobstructivepulmonarydiseasepatientsepidemiologyinjapan
AT hagangerry prevalenceofairflowlimitationinsubjectsundergoingcomprehensivehealthexaminationinjapansurveyofchronicobstructivepulmonarydiseasepatientsepidemiologyinjapan